Can Stored Blood Show More Free THCCOOH Without New Cannabis Exposure?

Yes. In a controlled storage study, free THCCOOH increased in some blood samples while its glucuronide decreased. Because these were stored specimens, that change did not represent new cannabis exposure. It demonstrates why the chemical form and storage history belong in an interpretation.

The samples came from actual cannabis exposure

The investigators studied blood and plasma collected from ten participants after controlled cannabis smoking. They prepared lower- and higher-concentration pools from each participant and compared different storage times and temperatures with early measurements.

These were authentic human specimens, not only blank blood fortified with standards. That distinction matters because binding and other matrix characteristics in authentic samples can differ from those in spiked validation materials.

Free metabolite and conjugate did not move together

After one week at room temperature, free THCCOOH increased in both lower- and higher-concentration blood pools, while THCCOOH-glucuronide decreased. At refrigerated temperature, increases in free THCCOOH also appeared in the lower-concentration pools after longer storage. The same pattern did not apply uniformly to every pool or condition.

The authors examined the molar sum of free metabolite and conjugate as well as individual concentrations. This helps distinguish conversion between chemical forms from a simple claim that all cannabinoid material either remained unchanged or disappeared.

Why a later result needs its own context

A repeat test may legitimately differ because the stored material changed. That possibility does not prove that every discrepancy is caused by glucuronide breakdown, and the study cannot provide a universal correction factor for a different tube, preservative, temperature or storage interval.

Review the collection and separation records, storage temperature, elapsed time, analytes reported and whether hydrolysis was performed. Whole blood and plasma should also remain separate: the paper documented matrix-specific stability rather than one interchangeable cannabinoid shelf life.

THCCOOH is an exposure-related metabolite. A storage-related increase in its free form supplies neither a new-use event nor a measure of contemporaneous impairment. Our article on THC concentration and impairment explains that further distinction. The practical lesson is to compare like analytes under documented conditions before attributing a changed number to changed human behavior.

Primary research

Karl B. Scheidweiler and colleagues. Clinical chemistry (2013). In Vitro Stability of Free and Glucuronidated Cannabinoids in Blood and Plasma Following Controlled Smoked Cannabis.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Other Medications Changed THC/CBD Spray Exposure in Different Directions

The effect of another medication on THC/CBD exposure depends on the drug and the pathway involved. A human interaction study found lower cannabinoid exposure with rifampicin, higher exposure with ketoconazole, and no significant pharmacokinetic change with omeprazole under the tested conditions. Three separate crossover comparisons Stott and colleagues studied 36…

Spread the love

Read Article: Other Medications Changed THC/CBD Spray Exposure in Different Directions

An Intermediate CBD Stress Response Was Not a Significant Placebo Difference

A CBD group’s average response can fall between placebo patients and healthy controls without demonstrating a significant CBD-versus-placebo benefit. A study of social stress in people at clinical high risk of psychosis illustrates this statistical distinction. Stress hormones and subjective symptoms were separate endpoints Participants at clinical high risk received…

Spread the love

Read Article: An Intermediate CBD Stress Response Was Not a Significant Placebo Difference

Two-Dimensional Cannabis GC–MS Testing Needs Correctly Timed Transfer Windows

Adding a second chromatography column can improve cannabinoid separation while introducing a new failure point: the analyte must reach the second column during the correct transfer window. A plasma assay study showed why those windows require verification. More separation brought more timing requirements Karschner and colleagues developed two-dimensional gas chromatography–mass…

Spread the love

Read Article: Two-Dimensional Cannabis GC–MS Testing Needs Correctly Timed Transfer Windows

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us